心不全の低射出率 (HFrEF) に関する世界的な実用データ:最適化における課題と性差
Andrea Attanasio1,2, Gianluigi Guida1,2, Giandomenico Disabato1,2
1Cardiology University Department, IRCCS Policlinico San Donato, Piazza Edmondo Malan, Milan 20097, Italy.
European heart journal. Quality of care & clinical outcomes
|September 3, 2025
まとめ
ガイドラインに準拠した医療療法 (GDMT) を処方することで,心不全のエジェクション分数 (HFrEF) が減少すると,死亡率が著しく低下します. しかし,特に高齢の患者では,治療開始における臨床的慣性が残っており,GDMTの遵守を向上させる必要があることを強調しています.
科学分野:
- 心臓病科
- 薬理学について
- 臨床医学
背景:
- HFrEFの治療は進んでいるが,ガイドライン指向の医療療法 (GDMT) の処方における臨床的惰性は一般的である.
- GDMTには,HFrEFの管理に不可欠な4つの主な薬類が含まれています.
- GDMTの処方箋の遵守とタイミングを理解することは,患者の結果を改善するために不可欠です.
研究 の 目的:
- HFrEF患者の死亡率に対するGDMT処方箋の遵守とタイミングの影響を評価する.
- 性別によるGDMTの処方と結果の潜在的な違いを評価する.
- 最適なGDMT利用への障壁を特定する.
主な方法:
- トリネットXのデータベースを用いたグローバルコホートによる遡及分析.
- HFrEFの患者は,処方されたGDMTのクラス数に基づいて4つのグループに分けられました.
- 主要エンドポイントは全因死亡率で,二次分析では治療の4倍化までの時間と性差が検討された.
主要な成果:
- HFrEF患者の20%だけが四重治療を達成し,ミネラルコルチコイド受容体アンタゴニスト (MRA) とSGLT2阻害剤 (SGLT2i) が特に高齢/弱体患者で最も少なく処方されました.
- 追加されたGDMTクラスは,死亡率を著しく低下させた (p < 0. 001).
- 最初の1年以内に治療を4倍にする時間は死亡率に有意な影響を及ぼさなかった.生存における有意な性別差は観察されなかった.
結論:
- HFrEFに対するGDMTの処方における臨床的惰性は,特に脆弱な患者グループにおける最適な治療への重要な障壁です.
- HFrEFの薬効性および患者特性の性別による差異に対処するためにさらなる研究が必要です.
- HFrEFにおける生存率の改善には,臨床慣性の克服のための戦略が不可欠である.
関連する概念動画
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Heart Failure I: Introduction
52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
Heart Failure III: Clinical Manifestations
42
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
42
Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32


